MINIPRESS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Minipress, and what generic alternatives are available?
Minipress is a drug marketed by Pfizer and is included in two NDAs.
The generic ingredient in MINIPRESS is prazosin hydrochloride. There are seventeen drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the prazosin hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Minipress
A generic version of MINIPRESS was approved as prazosin hydrochloride by TEVA PHARMS on September 12th, 1988.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MINIPRESS?
- What are the global sales for MINIPRESS?
- What is Average Wholesale Price for MINIPRESS?
Summary for MINIPRESS
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 117 |
Clinical Trials: | 27 |
Patent Applications: | 1,782 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for MINIPRESS |
What excipients (inactive ingredients) are in MINIPRESS? | MINIPRESS excipients list |
DailyMed Link: | MINIPRESS at DailyMed |
![MINIPRESS drug patent expirations Drug patent expirations by year for MINIPRESS](/p/graph/s/t/MINIPRESS-patent-expirations.png)
![Drug Prices for MINIPRESS](/p/graph/drug-price/MINIPRESS.png)
Recent Clinical Trials for MINIPRESS
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Yale University | Phase 1/Phase 2 |
University of Washington | Phase 4 |
Johns Hopkins University | Phase 2 |
US Patents and Regulatory Information for MINIPRESS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | MINIPRESS | prazosin hydrochloride | CAPSULE;ORAL | 017442-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Pfizer | MINIPRESS XL | prazosin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 019775-001 | Jan 29, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pfizer | MINIPRESS | prazosin hydrochloride | CAPSULE;ORAL | 017442-003 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Pfizer | MINIPRESS | prazosin hydrochloride | CAPSULE;ORAL | 017442-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Pfizer | MINIPRESS XL | prazosin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 019775-002 | Jan 29, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MINIPRESS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | MINIPRESS | prazosin hydrochloride | CAPSULE;ORAL | 017442-003 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | MINIPRESS | prazosin hydrochloride | CAPSULE;ORAL | 017442-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | MINIPRESS | prazosin hydrochloride | CAPSULE;ORAL | 017442-003 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | MINIPRESS | prazosin hydrochloride | CAPSULE;ORAL | 017442-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | MINIPRESS | prazosin hydrochloride | CAPSULE;ORAL | 017442-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | MINIPRESS | prazosin hydrochloride | CAPSULE;ORAL | 017442-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MINIPRESS
See the table below for patents covering MINIPRESS around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Malaysia | 8100271 | NOVEL CRYSTALLINE FORMS OF PRAZOSIN HYDROCHLORIDE | ⤷ Sign Up |
Poland | 196354 | ⤷ Sign Up | |
U.S.S.R. | 644387 | METHOD OF OBTAINING CRYSTALLINE A-FORM OF 2-/4-(2-FUROYL)-PIPERAZIN-1-YL/-4-AMINO-6,7-DIMETHOXYQUINAZOLINEHYDROCHLORIDE | ⤷ Sign Up |
Denmark | 86877 | ⤷ Sign Up | |
Sweden | 423234 | FORFARANDE FOR FRAMSTELLNING AV DEN KRISTALLINA 2-FORMEN AV 2-/4-(2-FUROYL)-PIPERAZIN-1-YL/-4 AMINO-6,7-DIMETOXI-KINAZOLINHYDROKLORID | ⤷ Sign Up |
Bulgaria | 29724 | METOD ZA POLUCHAVANE NA KRISTALNA- ALFA- FORMA NA PRAZOSIN KHIDROKHLORID (METHOD FOR OBTAINING OF CRISTAL- ALFA- FROM OF PRAZOCIN HYDROCHLORIDE) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |